Noncompartmental pharmacokinetic analysis (NCA) was performed using Phoenix WinNonLin, version 6.4 (Mountain View, CA), given the data-rich nature of the sampling schema. The following parameters were derived by NCA: maximum concentration (Cmax), time to maximum concentration (Tmax), last measurable concentration (Clast), time to last measurable concentration (Tlast), area under the curve from time zero to the last measurable concentration (AUC0–last), area under the curve from time zero to infinity (AUC0–∞), volume of distribution during the terminal phase after intravenous administration (Vz), clearance (CL), and terminal half-life. Between-group comparisons of matched subjects were performed using the Wilcoxon matched-pair signed-rank test and Fisher's exact test for categorical variables. Visual inspection of the scatterplot matrix, Pearson's correlation (R), and ordinary least-square regression were used to assess the relationships between pharmacokinetic system parameters (CL and Vz) and body size. In addition, nonlinear regression (power function) was used to compare pharmacokinetic system parameters to weightβ and α(weight/median weight)β, where β is an exponent and α is a constant function of weight. Discrimination between models was performed based on the coefficient of determination (R2) and the Akaike information criterion (AIC). All statistical analyses were implemented through STATA SE, version 13.1.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.